Tags

Type your tag names separated by a space and hit enter

Mii-vitaliSe: a pilot randomised controlled trial of a home gaming system (Nintendo Wii) to increase activity levels, vitality and well-being in people with multiple sclerosis.
BMJ Open. 2017 Sep 27; 7(9):e016966.BO

Abstract

OBJECTIVES

While the health and well-being benefits of physical activity are recognised, people with multiple sclerosis (MS) often face greater barriers than the general population. The Nintendo Wii potentially offers a fun, convenient way of overcoming some of these. The aim was to test the feasibility of conducting a definitive trial of the effectiveness and cost-effectiveness of Mii-vitaliSe; a home-based, physiotherapist-supported Nintendo Wii intervention.

DESIGN

A single-centre wait-list randomised controlled study.

SETTING

MS service in secondary care.

PARTICIPANTS

Ambulatory, relatively inactive people with clinically confirmed MS.

INTERVENTION

Thirty participants were randomised to receive Mii-vitaliSe either immediately (for 12 months) or after a 6-month wait (for 6 months). Mii-vitaliSe consisted of two supervised Nintendo Wii familiarisation sessions in the hospital followed by home use (Wii Sports, Sports Resort and Fit Plus software) with physiotherapist support and personalised resources.

OUTCOMES

Included self-reported physical activity levels, quality of life, mood, self-efficacy, fatigue and assessments of balance, gait, mobility and hand dexterity at baseline, 6 and 12 months. Interviews (n=25) explored participants' experiences and, at study end, the two Mii-vitaliSe facilitators' experiences of intervention delivery (main qualitative findings reported separately).

RESULTS

Mean (SD) age was 49.3 (8.7) years, 90% female, with 47% diagnosed with MS <6 years ago and 60% new to active gaming. The recruitment rate was 31% (95% CI 20% to 44%). Outcome data were available for 29 (97%) at 6 months and 28 (93%) at 12 months. No serious adverse events were reported during the study. Qualitative data indicated that Mii-vitaliSe was well-received. Mean Wii use across both groups over the initial 6-month intervention period was twice a week for 27 min/day. Mean cost of delivering Mii-vitaliSe was £684 per person.

DISCUSSION

Mii-vitaliSe appears acceptable and a future trial feasible and warranted. These findings will inform its design.

TRIAL REGISTRATION

ISRCTN49286846.

Authors+Show Affiliations

Bournemouth University, Faculty of Health and Social Sciences, Bournemouth, Dorset, UK.Bournemouth University, Faculty of Health and Social Sciences, Bournemouth, Dorset, UK.Bournemouth University, Faculty of Health and Social Sciences, Bournemouth, Dorset, UK.Poole Hospital NHS Foundation Trust, Dorset Multiple Sclerosis Service, Poole, Dorset, UK.Poole Hospital NHS Foundation Trust, Dorset Multiple Sclerosis Service, Poole, Dorset, UK.Poole Hospital NHS Foundation Trust, Medical Physics, Poole, Dorset, UK.National Star College, Cheltenham, Gloucestershire, UK.Bournemouth University, Faculty of Health and Social Sciences, Bournemouth, Dorset, UK.Bournemouth University, Faculty of Health and Social Sciences, Bournemouth, Dorset, UK.Service user, Bournemouth, UK.Service user, Bournemouth, UK.Poole Hospital NHS Foundation Trust, Dorset Multiple Sclerosis Service, Poole, Dorset, UK.

Pub Type(s)

Journal Article
Randomized Controlled Trial

Language

eng

PubMed ID

28954791

Citation

Thomas, Sarah, et al. "Mii-vitaliSe: a Pilot Randomised Controlled Trial of a Home Gaming System (Nintendo Wii) to Increase Activity Levels, Vitality and Well-being in People With Multiple Sclerosis." BMJ Open, vol. 7, no. 9, 2017, pp. e016966.
Thomas S, Fazakarley L, Thomas PW, et al. Mii-vitaliSe: a pilot randomised controlled trial of a home gaming system (Nintendo Wii) to increase activity levels, vitality and well-being in people with multiple sclerosis. BMJ Open. 2017;7(9):e016966.
Thomas, S., Fazakarley, L., Thomas, P. W., Collyer, S., Brenton, S., Perring, S., Scott, R., Thomas, F., Thomas, C., Jones, K., Hickson, J., & Hillier, C. (2017). Mii-vitaliSe: a pilot randomised controlled trial of a home gaming system (Nintendo Wii) to increase activity levels, vitality and well-being in people with multiple sclerosis. BMJ Open, 7(9), e016966. https://doi.org/10.1136/bmjopen-2017-016966
Thomas S, et al. Mii-vitaliSe: a Pilot Randomised Controlled Trial of a Home Gaming System (Nintendo Wii) to Increase Activity Levels, Vitality and Well-being in People With Multiple Sclerosis. BMJ Open. 2017 Sep 27;7(9):e016966. PubMed PMID: 28954791.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Mii-vitaliSe: a pilot randomised controlled trial of a home gaming system (Nintendo Wii) to increase activity levels, vitality and well-being in people with multiple sclerosis. AU - Thomas,Sarah, AU - Fazakarley,Louise, AU - Thomas,Peter W, AU - Collyer,Sarah, AU - Brenton,Sarah, AU - Perring,Steve, AU - Scott,Rebecca, AU - Thomas,Fern, AU - Thomas,Charlotte, AU - Jones,Kelly, AU - Hickson,Jo, AU - Hillier,Charles, Y1 - 2017/09/27/ PY - 2017/9/29/entrez PY - 2017/9/29/pubmed PY - 2018/6/1/medline KW - Active Gaming KW - Behaviour change KW - Exercise KW - Feasibility KW - Multiple Sclerosis KW - Physical Activity KW - Virtual Reality SP - e016966 EP - e016966 JF - BMJ open JO - BMJ Open VL - 7 IS - 9 N2 - OBJECTIVES: While the health and well-being benefits of physical activity are recognised, people with multiple sclerosis (MS) often face greater barriers than the general population. The Nintendo Wii potentially offers a fun, convenient way of overcoming some of these. The aim was to test the feasibility of conducting a definitive trial of the effectiveness and cost-effectiveness of Mii-vitaliSe; a home-based, physiotherapist-supported Nintendo Wii intervention. DESIGN: A single-centre wait-list randomised controlled study. SETTING: MS service in secondary care. PARTICIPANTS: Ambulatory, relatively inactive people with clinically confirmed MS. INTERVENTION: Thirty participants were randomised to receive Mii-vitaliSe either immediately (for 12 months) or after a 6-month wait (for 6 months). Mii-vitaliSe consisted of two supervised Nintendo Wii familiarisation sessions in the hospital followed by home use (Wii Sports, Sports Resort and Fit Plus software) with physiotherapist support and personalised resources. OUTCOMES: Included self-reported physical activity levels, quality of life, mood, self-efficacy, fatigue and assessments of balance, gait, mobility and hand dexterity at baseline, 6 and 12 months. Interviews (n=25) explored participants' experiences and, at study end, the two Mii-vitaliSe facilitators' experiences of intervention delivery (main qualitative findings reported separately). RESULTS: Mean (SD) age was 49.3 (8.7) years, 90% female, with 47% diagnosed with MS <6 years ago and 60% new to active gaming. The recruitment rate was 31% (95% CI 20% to 44%). Outcome data were available for 29 (97%) at 6 months and 28 (93%) at 12 months. No serious adverse events were reported during the study. Qualitative data indicated that Mii-vitaliSe was well-received. Mean Wii use across both groups over the initial 6-month intervention period was twice a week for 27 min/day. Mean cost of delivering Mii-vitaliSe was £684 per person. DISCUSSION: Mii-vitaliSe appears acceptable and a future trial feasible and warranted. These findings will inform its design. TRIAL REGISTRATION: ISRCTN49286846. SN - 2044-6055 UR - https://www.unboundmedicine.com/medline/citation/28954791/Mii_vitaliSe:_a_pilot_randomised_controlled_trial_of_a_home_gaming_system__Nintendo_Wii__to_increase_activity_levels_vitality_and_well_being_in_people_with_multiple_sclerosis_ L2 - https://bmjopen.bmj.com/lookup/pmidlookup?view=long&amp;pmid=28954791 DB - PRIME DP - Unbound Medicine ER -